Q&A: U Maryland's James Mixson Discusses Developing Novel Polyplexes for siRNA Delivery

In addition to the work done in his lab, Mixson has been collaborating with a number of RNAi drug developers, including Intradigm and Sirnaomics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.